Förderung der Kinder- und Jugendgesundheit in Nordrhein-Westfalen

INTERPLAYs Vision ist die frühe Förderung der Kinder- und Jugendgesundheit mit direkter Implementierung neuer Strategien aus der Präventions- und Versorgungsforschung.

ABCDE: Partnerinstitutionen

Principle Investigators at RWTH Aachen University, Aachen

  • Univ.-Prof. Dr. Beate Herpertz-Dahlmann
    Dept. of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
  • Univ.-Prof. Dr. Stefan Jockenhövel
    Dept. of Biohybrid and Medical Textiles, Institute of Applied Medical Engineering
  • Univ.-Prof. Dr. Kerstin Konrad
    Dept.of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
  • Univ.-Prof. Dr.-Ing. Dr. med. Dr. h. c. Steffen Leonhardt
    Dept. for Medical Information Technology, Helmholtz-Institute for Biomedical Engineering
  • Prof. Dr. Klaus Tenbrock
    Dept. of Pediatric and Adolescent Medicine
  • Univ.-Prof. Dr. Norbert Wagner
    Dept. of Pediatric and Adolescent Medicine

Principle Investigators at Ruhr University Bochum, Bochum

  • Univ.- Prof. Dr. Sigrid Elsenbruch
    Dept. of Medical Psychology and Medical Sociology
  • PD Dr. Corinna Grasemann
    Dept. of Pediatrics
  • Univ.-Prof. Dr. Martin Holtmann
    LWL-University Hospital Hamm for Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics
  • Univ.-Prof. Dr. Tanja Legenbauer
    LWL-University Hospital Hamm for Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics
  • Univ.-Prof. Dr. Thomas Lücke
    Dept. of Pediatrics
  • Univ.-Prof. Dr. Konstanze Winklhofer
    Institute of Biochemistry and Pathobiochemistry

Principle Investigators at University of Cologne, Cologne

  • Jun. Prof. Dr. Dr. Miguel A. Alejandre Alcazar
    Dept. of Pediatric and Adolescent Medicine
  • Univ.- Prof. Dr. Stephan Bender
    Dept. of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
  • Univ.- Prof. Dr. Jens Boenisch
    Dept. for Special Education and Rehabilitation
  • Univ.-Prof. Dr. Bent Brachvogel
    Dept. of Pediatric and Adolescent Medicine
  • Univ.- Prof. Dr. Manfred Döpfner
    Dept. of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy and School of Child and Adolescent Cognitive Behavior Therapy
  • Univ.-Prof. Dr. Mathias Fischer
    Dept. of Pediatric and Adolescent Medicine
  • PD Dr. Max Liebau
    Dept. of Pediatric and Adolescent Medicine
  • Univ.- Prof. Dr. Holger Pfaff
    Institute for Medical Sociology, Health Services Research and Rehabilitation Science

Principle Investigators at Heinrich-Heine University of Duesseldorf, Faculty of Medicine, Duesseldorf

  • Univ.-Prof. Dr. Arndt Borkhardt
    Dept. of Pediatric Oncology, Hematology and Clinical Immunology
  • Prof. Dr. Felix Distelmaier
    Dept. of General Pediatrics, Neonatology and Pediatric Cardiology
  • Prof. Dr. Regina Ensenauer
    Dept. of General Pediatrics, Neonatology and Pediatric Cardiology and Dept. of Child Nutrition, Max Rubner-Institut
  • Univ.-Prof. Dr. Ertan Mayatepek
    Dept. of General Pediatrics, Neonatology and Pediatric Cardiology
  • Prof. Roland Meisel
    Dept. of Pediatric Oncology, Hematology and Clinical Immunology
  • Prof. Thomas Meissner
    Dept. of General Pediatrics, Neonatology and Pediatric Cardiology
  • Univ.-Prof. Dr. Marc Remke
    Dept. of Pediatric Oncology, Hematology and Clinical Immunology

Principle Investigators at University of Duisburg-Essen, Faculty of Medicine, Essen

  • Dr. Thurid Ahlenstiel-Grunow
    Dept. of Pediatrics II
  • Univ.-Prof. Dr. Ursula Felderhoff-Müser
    Dept. of Pediatrics I
  • Univ.-Prof. Dr. Johannes Hebebrand
    Dept. of Child and Adolescent Psychiatry
  • PD Dr. Josephine Herz
    Dept. of Pediatrics I
  • Univ.-Prof. Dr. Anke Hinney
    Dept. of Child and Adolescent Psychiatry
  • Univ.-Prof. Dr. Lars Pape
    Dept. of Pediatrics II
  • Univ.-Prof. Dr. Dirk Reinhardt
    Dept. of Pediatrics III

Principle Investigators at Max Planck Institute for Metabolism Research, Cologne

  • Univ.-Prof. Dr. Jens Brüning
    Max-Planck-Institut für Stoffwechselforschung

Principle Investigators at German Sports University, Cologne

  • Prof. Dr. Dr. Christine Joisten
    Dept. for Physical Activity in Public Health, Institute of Movement and Neurosciences

Principle Investigators at Federal Centre for Health Education, Cologne

  • Prof. Dr. Freia De Bock
    Dept. 2 and Director of Research at Federal Centre for Health Education

Principle Investigators at Research Center Jülich, Juelich

  • Univ.-Prof. Dr. Simon Eickhoff
    Institute of Neuroscience and Medicine (INM-7)

Strukturen, Patientenkohorten und Kooperationen

Wir bieten exzellente Grundlagenforscher*innen, klinische Wissenschaftler*innen, große Patientenkohorten, kommunale Krankenhäuser, Krankenversicherungen, Patientenvertreter*innen und Zugang zu Schulen.
INTERPLAY vereint 2 Exzellenzcluster, 4 Sonderforschungsbereiche, 2 Forschergruppen, 2 Graduiertenkollege und 4 Partnerinstitutionen.

Name Location / Principle Investigators Objective and funding body
Anorexia nervosa registry A / Herpertz-Dahlmann,
B /Legenbauer, E / Hebebrand		 Registry with ca. 700 Anorexia nervosa patients in Germany, Funding: intramural
RCT A / Herpertz-Dahlmann Home treatment program in anorexia nervosa, Funding: G-BA Innovation fund
PRO-KIND cohort A / Tenbrock, Wagner Worldwide largest cohort of treatment-naive patients with pediatric rheumatic diseases (app. 500 patients), Funding: G-BA Innovation fund
CEDATA A / Wagner Long term follow up of mor than 5.000 pediaric patients with inflammatory bowel disease, national register
JODA-MALTREAT database A / Konrad Joint database for studies on the effects of childhood maltreatment, Funding: BMBF
ESCAlife A / Herpertz-Dahlmann,
B / Holtmann,
C / Doepfner		 Stepped Care of ADHD along the life-span, Funding: BMBF
Mighty U B / Lücke Program to support child patients in therapy through virtual reality, Funding: BMBF
CARE FAM NET´ B / Lücke,
C / Bender
E / Hebebrand 		The CARE-FAM-NET (incl. > 40 consortium partners) aimed to close the existing gap in psychosocial care for families with affected children and adolescents, Funding: G-BA Innovation fund
ESG-study B/ Grasemann
E / Hebebrand, Hinney		 Assessment of hormonal and nutritional status in >400 children and adolescents with depressive symptoms, Funding: intramural
European Reference Networks
MetabERN, Endo-ERN, ERK-Net, ERN-EuroBloodNet, ERN-Paedcan, ENERCA, ERN-Lung		 A / B / C / D / E European Reference Networks (ERN) for metabolism, endocrinology, hematology, oncology, rare congenital anaemias, and pulmonology, Funding: EU
ADOPT C / Doepfner Optimization of prevention and therapy in patients with affective dysregulation, Funding: BMBF
B-FAST C / Bender, Doetsch Applied surveillance Covid-19 in day care centers and schools, Funding: BMBF
HSR-NICU, NEO-CamCare, and NEO-MILK C / Pfaff Implementation of health services research to improve care of very-low-birth infants in neonatal intensive care units (HSR-NICU), e.g. using webcams (NeoCamCare) or via implementation of donor milk banks and structured breastfeeding strategies (NEO-Milk), Funding: G-BA Innovation fund
National reference center for molecular diagnostics in neuroblastoma and national biobank for neuroblastoma C / Fischer Analysis of the postnatal parental-newborn skin-skin contact for stress programming, Funding: BMBF
ForMe/ ARegPKD / ADPedKD registers C / Liebau, Liebau,
E / Pape, Ahlenstiel-Grunow		 Clinical characterization of patients suffering from nephrotic syndrome (ForMe) and hepatorenal diseases (ARegPKD, ADPedKD), Funding: DFG, BMBF, Marga&Walter Boll foundation, intramural
ADEBAR C / Joisten (DSHS) Obesity prevention through a nutrition- and exercise-based family program, Funding: Marga&Walter Boll foundation
CHILT-III C / Joisten (DSHS) Outpatient multidisciplinary family-based program for obese children (ca. 500), Funding: health insurance (AOK), intramural
CoRe-Net C / Pfaff Research network for the care of vulnerable patient groups with a comprehensive database containing GKV routine data of 4 cooperating german health insurances, Funding: BMBF
PARTCHILD program C / De Bock (BZgA) Improving the quality of care for children with chronic diseases and disabilities in social pediatric centers, Funding: G-BA Innovation fund
PEACHES cohort
(Programming of enhanced adiposity risk in childhood – early screening)		 D / Ensenauer 1707 pairs of mothers (with pregestational obesity) and children, including biobank and biosamples. Funding: BMBF
PEPO cohort
(Perinatal prevention of obesity development)		 D / Ensenauer 11,730 mother-child pairs analyzing the longitudinal effects of prepregnancy BMI and gestational weight gain on offspring. Funding: BMBF
BEARR (Breastfeeding education for risk reduction) project D / Ensenauer Extensive breastfeeding support program for obese mothers at high-risk of diabetes as an early preventive measure for mother and child. Funding: Foundation for Cardiovascular Prevention in Childhood, Ludwig-Maximilians-Universität München
COACH. Chronic Conditions in Adolescents: Implementation and Evaluation of Patient-centred Collaborative Health Care D / Meissner Motivational Interviewing as a tool to enhance access to mental health treatment in adolescents with chronic medical conditions and need for psychological support (COACH-MI); Funding: BMBF
Preterm Follow-up cohort (partner of GNN) E / Felderhoff-Müser > 1000 preterm born infants (<32 weeks gestation) with MRI at TEA (>1100 scans), aEEG in the first 72hrs of life, GMA, HINE etc., and long-term neurodevelopmental follow-up. Funding: Mercator, BMBF
NEOCYST (Network for early onset cystic kidney disease) E / Pape
C / Liebau		 NEOCYST network aimed to improve knowledge of the genetics, molecular pathophysiology, and long-term prognosis of cystic kidney disease, Funding: BMBF
Active Onco Kids network E / Reinhardt, C /Fischer Large German Cancer Aid-funded national network to promote and evaluate the benefits of sports in severe and chronic diseases, Funding: German Cancer Aid
TELE-KASPER E / PI Felderhoff-Müser Antibiotic Stewardship in Pediatrics – interprofessional telemedicine network, Funding: G-BA Innovation fund
CARE for CAYA project E / Reinhardt Prevention program for young patients after surviving cancer in childhood, adolescence, and young adulthood, Funding: G-BA Innovation fund
KTX360° E / Ahlenstiel-Grunow, Pape A multicenter, multisectoral, multimodal, telemedicine-based followup care model to improve care and reduce health care costs after kidney transplantation in children and adults, Funding: G-BA Innovation fund
Name Location / Principle Investigators Project title
CRC 1382
Gut-liver axis		 A / Wagner Coordination of gut-liver communication by directed immune cell migration (B02)
CRC 1280
Extinction learning		 B / Elsenbruch From Pavlov to pain: extinction learning in visceral pain (A10)
The impact of inflammation on the extinction of pain-related fear in humans (A12)
CRC289
Treatment expectation		 B / Elsenbruch Effects of negative expectations on visceroception and visceral pain (TP04)
CRC1399
Mechanisms of drug sensitivity and resistance in small cell lung cancer		 C / Fischer Targeting telomere maintenance mechanisms in SCLC (A03)
CRC 1451
Motor control		 C / Bender Multidimensional aspects including the development of motor control
iRTG 2150 A / Konrad, Eickhoff (RCJ) The Neuroscience of Modulating Aggression and Impulsivity in Psychopathology
RTG 2576 D / Ensenauer In vivo investigations towards the early development of type 2 diabetes (vivid)
RU FOR2722
Musculoskeletal extracellular matrix		 C / Brachvogel, Dötsch Mitochondrial dysfunction in cartilage and its consequences for ECM and joint homeostasis (M1); Musculoskeletal ECM-induced reprogramming of the metabolic system (M2)
CRU 337
Phenotypic therapy and immune escape in cancer (PhenoTime)		 D / Remke Identification and functional characterization of long non-coding RNAs as epigenetic determinants of therapy resistance in BRAF-driven cancers (P6)
RESOLV
Excellence Cluster		 B / Winklhofer Cellular quality control and stress response pathways in neurodegeneration
CECAD
Excellence Cluster		 C / Alejandre Alcazar, Brüning Metabolic origins of premature ageing of the lung (Alejandre Alcazar); Regulation of food intake and influences energy availability in the body (Brüning)
West German Genome Center (WGGC) A / C / D/ E DFG-funded collaborative network, one of four national Next Generation Sequencing Competence Centers
Leibniz Center for Diabetes Research D / Meissner State-of-the-art research center for diabetes.
Institute of Human Genetics D / Borkhardt Analysis of genetic causes of disease
Dept.s of Computational Cancer Biology, Translational Genomics and Institute for Pathology C / Fischer Computer-based analyses of the tumor biology and micro-environment.
Seven collaborating community-based hospitals for Pediatrics and Child&Adolescent Medicine in NRW ABCDE / INTERPLAY Within NRW, six Clinics for pediatrics or Clinics for child & adolescent psychiatry committed to collaborate in ongoing and future patient’s cohorts and research activities in INTERPLAY.
Bielefeld (https://evkb.de/);
Cologne (https://www.kliniken-koeln.de/);
Dortmund (https://www.klinikumdo.de/);
Duesseldorf (https://www.evk-duesseldorf.de/);
Krefeld (https://www.helios-gesundheit.de/kliniken/krefeld/);
Minden (https://www.muehlenkreiskliniken.de/);
Viersen (https://klinik-viersen.lvr.de/).
Regional state youth welfare organizations ABCDE / INTERPLAY Both regional state youth welfare organizations support INTERPLAY
LVR-Regional Children (www.lvr.de); LWL-Regional (www.lwl.org)
Name Location / Principle Investigators Project title
German Diabetes Centre (DZD) C / Brüning
German Centre for Lung Research (DZL) C / Alejandre Alcazar Converging signaling pathways in neonatal lung regeneration
German Cancer Consortium for Translational Cancer Research (DKTK) D/ Marc Remke Pediatric Neuro-Oncogenomics
Max Rubner-Institut (MRI) - Federal Research Institute of Nutrition and Food D / Ensenauer (Head of the Dept. of Child Nutrition) Developmental origins of obesity and nutrition-related diseases
TU Munich and Leibniz-Institute for Food Systems Biology D / Ensenauer Developmental origins of obesity and nutrition-related diseases
German Neonatal Network (GNN) E / Felderhoff-Müser Early markes for neurological outcome of preterm infants
German Centre for Cardiovascular Research (DZHK) E / Felderhoff-Müser Cardiovascular complication in pregnancy – neurodevelopmental outcome
NAKO Working Group “Birth Cohort” Speaker: Dr. Börge Schmidt
https://nako.de/		 E/ Felderhoff-Müser The German National Cohort (NAKO) is a large-scale cohort study that investigates risk factors for a broad range of diseases (~200.000 participants aged 20-70 years; 18 study regions in Germany).
Four health insurances:
AOK Rheinland/Hamburg (https://www.aok.de/pk/rh/);
Barmer (https://www.barmer.de/);
DAK (https://www.dak.de/dak/);
IKK (https://www.ikk-classic.de/);
TK (https://www.tk.de/)		 ABCDE / INTERPLAY partner-site These health insurances have confirmed their interest in collaborating with INTERPLAY, e.g. by providing access to diseases information, expanding structures such as CoRe-Net (Table 2) or supporting advisory boards (Fig. 10).
Seven patients’ organizations ABCDE / INTERPLAY European Foundation for the Care of Newborn Infants (EFCNI; https://www.efcni.org/); German Rheumatism League NRW (https://www.rheuma-liga.de/); German Crohn's disease /Ulcerative colitis association (https://www.dccv.de/); rehaKIND (https://www.rehakind.de/); ADHD association (http://www.adhs-deutschland.de/); Löwenstern (support for children with cancer; https://www.loewenstern-ev.de/); Child Protection Association (www.kinderschutzbund.de)
Name University Hospital Project title
European Network on Hyperkinetic Disorders (EUNETHYDIS) A / Konrad, B / Holtmann, C / Doepfner Hyperkinetic disorders in children and adolescents
Connect4children B / Lücke
E / Felderhoff-Müser		 Collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population
CERTAIN-Regsitry for Kidney and liver transplantation E / Pape
C / Liebau		 Co-Lead of Cooperative European Paediatric Renal Transplant Initiative
ARegPKD C / Liebau European network of paediatric nephrologists from 15 European countries in cooperation with geneticists collect clinical data of patients with ARPKD.
European ADHD Guidelines Group (EAGG) B / Holtmann,
C / Doepfner		 Attention deficit hyperactivity disorder in children and adolescents
CCB&B Development C / Boenisch Development of bilingual communication boards for students with complex communication needs.
LEGEND (Leukemia Gene Discovery) EU framework D / Borkhardt Identification of genetic variants that confer susceptibility for pediatric leukemia or lymphoma development
Harmony Alliance D / Borkhardt, Meisel
E / Reinhardt		 European Public-Private Partnership for big data in hematology
EU PREMSTEM consortium E / Felderhoff-Müser Mechanisms of stem cell therapy on different models of brain damage in premature infants
ENERCA E / Reinhardt European network for rare and congenital anaemias
Pediatric Acute Leukemia (PedAL)/European Pediatric Acute Leukemia (EuPAL) Initiative E / Reinhardt (Director of the consortium) Pediatric Acute Leukemia Initiative
Innovative Therapies for Children with Cancer Paediatric Preclinical Proof-of-concept Platform (ITCC) E / Reinhardt Development and establishment of preclinical models of high-risk pediatric solid tumors
EuRR-BONE; Registry of the ERN BOND B / Grasemann Development and establishment of a European Registry for Rare Bone Diseases
  • Forschungsschwerpunkte von INTERPLAY
    • Prä- und perinatale Ursprünge
    • Chronifizierungsprozesse
    • Gen-Umwelt-Interaktionen bei Tumorentwicklung, -therapie und -komorbiditäten
    • Interaktion von somatischer und psychischer Gesundheit
    • Präventions- und Versorgungsforschung
    • Innovative medizinische Technologien
    >
  • Ziele von INTERPLAY
    • INTERPLAY hat das Ziel, die Entstehungs- und Chronifizierungsmechanismen somatischer und psychischer Krankheiten sowie deren Interaktion in 6 Forschungsschwerpunkten zu entschlüsseln.
    • Dazu wird eine VIRTUELLE Plattform als Kommunikationsplattform und eine Akademie für Nachwuchswissenschaftler*innen etabliert.
    • Entwicklung einer Risikobewertung für chronische Erkrankungen sowie früher Präventions- und Therapiestrategien.
    • Die frühe Förderung der Kinder- und Jugendgesundheit mit direkter Implementierung unserer neuen Strategien im Zusammenspiel zwischen chronischen Erkrankungen und körperlicher und mentaler Entwicklung.
    • Die Entwicklung und Implementierung neuer Interventionsstrategien.
    >
Wir benutzen Cookies

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind essenziell für den Betrieb der Seite, während andere uns helfen, diese Website und die Nutzererfahrung zu verbessern (Tracking Cookies). Sie können selbst entscheiden, ob Sie die Cookies zulassen möchten. Bitte beachten Sie, dass bei einer Ablehnung womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen.

Akzeptieren Ablehnen
Weitere Informationen